Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tigecycline vs Ceftriaxone in Pediatric cIAI and CAP
NCT01602874Phase 3Withdrawn
- Sponsor
- Pfizer
- Start
- Jan 2011
- Primary completion
- May 2014
- Modality
- Orthosteric Ligands
01
Overview
A Phase 3 trial of tigecycline in Intra-abdominal infection (IAI), bacterial pneumonia, sponsored by Pfizer. Planned start Jan 2011; status: withdrawn.
02
Drugs
tigecycline
03
Conditions
Intra-abdominal infection (IAI)bacterial pneumonia
Beyond the preview
Go deeper on NCT01602874.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01602874.